Skip to main content
PEGASUS MERCANTILE INC. logo

PEGASUS MERCANTILE INC. — Investor Relations & Filings

Ticker · LOAN ISIN · CA70557Y2042 LEI · 529900BGK3BYC4VSF690 CSE Financial and insurance activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2023-04-17 Regulatory Filings
Country CA Canada
Listing CSE LOAN

About PEGASUS MERCANTILE INC.

https://xtacytherapeutics.com/

Pegasus Mercantile Inc. is a diversified venture capital firm and prospect generator that provides financial, operational, and management assistance to high-growth companies. The firm specializes as an incubator for early-stage investments within the wellness consumer goods market, focusing on biotechnology, hemp, CBD, functional mushrooms, and psychedelics. Its investment strategy targets solutions for chronic pain, depression, and mental illness, often utilizing pioneering techniques such as micro-dosing organic and synthetic compounds. Pegasus Mercantile assists portfolio companies from startup through commercialization, specializing in navigating complex regulatory requirements, including clinical trials, patenting, and legislative approvals. The firm also provides debt financing facilities.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-04-17 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification statement by the CFO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. It is a Form 52-109FV2, which is a certification of interim filings for a venture issuer. The document does not contain actual financial data or the interim report itself, but rather a certification of the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR). The document length is short (3034 characters), and it is clearly a certification letter, not the full interim report.
2023-04-03 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. It is a certification by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. The document does not contain actual financial statements or substantive financial data but is an officer certification related to interim filings. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself. The document length is short (3008 characters), and it is clearly a certification form, not the full interim report.
2023-04-03 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three months ended December 31, 2022 and 2021, which is a detailed explanation by management of the financial results and business outlook for a quarterly period. It includes financial data, business descriptions, acquisitions, outlook, and going concern discussion. The document is about 15,000 characters long, indicating it is a substantive report, not a brief announcement. The content is consistent with an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and contains detailed financial and operational analysis. There is no indication that this is an Annual Report (10-K) or just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2023
2023-04-03 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements For the three months ended December 31, 2022 Unaudited – Prepared by Management'. It contains detailed financial statements including statements of financial position, changes in shareholders' deficit, loss and comprehensive loss, cash flows, and notes to the financial statements. The period covered is a quarter (three months ended December 31, 2022). The document explicitly states it is unaudited and prepared by management, consistent with interim financial reporting. The presence of substantive financial data and analysis confirms it is a financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a status update announcement from Global Wellness Strategies Inc. regarding the filing of its annual financial statements and related MD&A, as well as the status of a management cease trade order (MCTO) issued by the British Columbia Securities Commission (BCSC). It mentions that the annual financial statements and MD&A have been filed on SEDAR, but the document itself does not contain the financial statements or detailed financial data. The document is relatively short (2940 characters) and serves as a status update rather than the actual report. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a general regulatory announcement and update about filing status and compliance, not the full annual report or interim report itself.
2023-03-30 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.